Recent News

Coordinated Approaches to Strengthen State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke

Chronic diseases, including heart disease, stroke, cancer, diabetes, and obesity, are the leading causes of death in the United States and account for most of the nation’s health care costs (1). Heart disease is the leading cause of death among men and women in the United States, accounting for 1 of every 4 deaths (1). Approximately 140,000 Americans die each year from stroke, and it is a leading…

AHRQ’s EvidenceNOW Initiative – Reducing Primary Care Patients’ Risk of Heart Attacks

Dr. David Meyers, M.D., AHRQ’s chief medical officer, recognizes the importance of February as Heart Health Month while highlighting important contributions made by AHRQ’s EvidenceNow initiative.

HHS Secretary Azar Statement on President Trump’s FY 2019 Budget

Azar: Plans to reduce high drug costs reflect President’s deep commitment to issue

Health and Human Services Secretary Alex Azar issued the following statement today on President Trump’s Fiscal Year 2019 Budget:

“The President’s budget makes investments and reforms that are vital to making our health and human services programs work for Americans and to sustaining them for…

NIH scientists adapt new brain disease test for Parkinson’s, dementia with Lewy bodies

National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson’s disease and dementia with Lewy bodies. The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people…

The Human Genome Project is awarded the Thai 2017 Prince Mahidol Award for the field of medicine

The Human Genome Project has been awarded the 2017 Prince Mahidol Award for ground-breaking advances in the field of medicine. The award will be received on behalf of the project by Eric Green, M.D., Ph.D., director of the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and the institute responsible for leading NIH’s effort in the project.